Trelegy Ellipta is a convenient once-daily inhaler designed for the management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. It features a powerful combination of three active ingredients: fluticasone furoate, which acts as a corticosteroid to reduce inflammation; umeclidinium, an anticholinergic that helps relax airway muscles; and vilanterol, a long-acting beta2-agonist that aids in easing breathing. Together, these medications work synergistically to enhance lung function, reduce the frequency of exacerbations, and manage symptoms such as wheezing and shortness of breath. The inhaler delivers medication in a dry powder form and includes a built-in dose counter for easy tracking. Please note, Trelegy Ellipta is not intended for immediate relief of breathing problems.